أفضل أطباء الكلى في إسطنبول - توب -63 أطباء

طبيب كلى

2019 - Halen, İstanbul/İstanbul/Türkiye

MEMORIAL BAHÇELİEVLER HASTANESİ

İç Hastalıkları ve Nefroloji Uzmanı

2018 - 2023, İstanbul/İstanbul/Türkiye

MEMORIAL ATAŞEHİR HASTANESİ

Nefroloji Uzmanı

2013 - 2018, Eskişehir/Eskişehir/Türkiye

ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ

Nefroloji Uzmanı

2011 - 2013, Batman/Batman/Türkiye

BATMAN DEVLET HASTANESİ

Nefroloji Uzmanı

2008 - 2011, Eskişehir/Eskişehir/Türkiye

ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ

Nefroloji Uzmanı

2007 - 2008, Eskişehir/Eskişehir/Türkiye

ESKİŞEHİR DEVLET HASTANESİ

Mecburi Hizmet

2001 - 2002, Artvin/Artvin/Türkiye

ARHAVİ DERECİK TOPLUM SAĞLIK MERKEZİ

Mecburi Hizmet

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.